DrugPatentWatch Database Preview
Patent: 8,962,010
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
Summary for Patent: 8,962,010
| Title: | Intravaginal drug delivery devices for the delivery of macromolecules and water-soluble drugs |
| Abstract: | An intravaginal drug delivery device comprises a device body comprising a hydrophobic carrier material having at least one channel defining at least one opening to the exterior of said device body, said at least one channel being adapted to receive at least one drug-containing insert; at least one drug-containing insert positioned in said at least one channel, said drug-containing insert capable of releasing a pharmaceutically effective amount of at least one drug suitable for intravaginal administration and containing about 1% to about 70% of at least one water-soluble release enhancer, both the drug and the water-soluble release enhancer dispersed in an insert carrier material; wherein said hydrophobic carrier material and said insert carrier material may be the same or different; and wherein said at least one drug-containing insert is exposed on said exterior of said device body when said intravaginal drug delivery device is in use. |
| Inventor(s): | Woolfson; David Aaron (Belfast, IE), Malcolm; Karl (Belfast, IE) |
| Assignee: | Warner Chilcott Company, LLC (Rockaway, NJ) |
| Application Number: | 12/147,310 |
| Patent Claims: | see list of patent claims |
Details for Patent 8,962,010
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nps Pharms Inc | NATPARA | parathyroid hormone | INJECTABLE;INJECTION | 125511 | 004 | 2015-01-23 | Start Trial | Warner Chilcott Company, LLC (Rockaway, NJ) | 2027-06-26 | RX | Orphan | search |
| Nps Pharms Inc | NATPARA | parathyroid hormone | INJECTABLE;INJECTION | 125511 | 003 | 2015-01-23 | Start Trial | Warner Chilcott Company, LLC (Rockaway, NJ) | 2027-06-26 | RX | Orphan | search |
| Nps Pharms Inc | NATPARA | parathyroid hormone | INJECTABLE;INJECTION | 125511 | 002 | 2015-01-23 | Start Trial | Warner Chilcott Company, LLC (Rockaway, NJ) | 2027-06-26 | RX | Orphan | search |
| Nps Pharms Inc | NATPARA | parathyroid hormone | INJECTABLE;INJECTION | 125511 | 001 | 2015-01-23 | Start Trial | Warner Chilcott Company, LLC (Rockaway, NJ) | 2027-06-26 | RX | Orphan | search |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patent Family for US Patent 8,962,010
| Country | Patent Number | Publication Date |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2009003125 | Dec 31, 2008 |
| World Intellectual Property Organization (WIPO) | 2009003125 | Feb 11, 2010 |
| United States of America | 2009004246 | Jan 01, 2009 |
| Singapore | 195525 | Dec 30, 2013 |
| Israel | 202614 | Jun 30, 2010 |
| Israel | 202614 | Sep 29, 2016 |
| >Country | >Patent Number | >Publication Date |
